Healthtech Startups
17,200 companies tagged Healthtech, with their investors and founders.
Ventis Medical develops portable emergency ventilators for emergency medical teams and EMS/transport settings as an alternative to manual bag valve devices. Its FDA-cleared HeroVent offers invasive and non-invasive ventilation modes with monitoring of volume, pressure, FiO2, and EtCO2.
0 investors
VentriFlo develops the VentriFlo True Pulse Pump, a blood pumping technology based on a suspended magnet linear motor coupled to a flexible diaphragm for cardiac surgery and perfusion applications. The company builds medical devices for hospitals and cardiac surgery programs.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Veravas develops the patented VeraBIND diagnostic platform that reduces interference in laboratory testing to measure hard-to-detect biomarkers, with a current application in blood-based early detection of tau pathology associated with Alzheimer's disease. It provides tests and sample pre-treatment solutions aimed at researchers and diagnostic labs for improved assay sensitivity and biomarker detection.</parameter> <parameter name="founders">[]
0 investors
Verda Bio conducts genetic and ingredient research on cannabinoids and rare plants to develop the basis for consumer products. It focuses on producing safe, consistent, and effective plant-derived ingredients.
0 investors
0 investors
0 investors
0 investors
0 investors
Veris Health offers the Veris Cancer Care Platform, which connects cancer patients and clinicians through symptom reporting, physiologic data from VerisBox connected devices, secure messaging, and video calls. It provides a clinician portal with EHR integration, quality-of-life assessments, and a patient app designed for value-based oncology care aligned with the Enhancing Oncology Model.
0 investors
Verismo is a biopharmaceutical company founded by the inventors of Kymriah, the first FDA-approved CAR T cell therapy, developing next-generation CAR T therapies using KIR receptor technology to address limitations in first-generation approaches.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Verndari develops the VaxiPatch, a single-dose vaccination kit that uses intradermal microarray technology for vaccine delivery. The company focuses on vaccine delivery methods designed to be pain-free and thermostable, with pre-clinical studies indicating higher efficacy than traditional delivery.
0 investors
0 investors